The Combination of Berberine and Methotrexate Enhances Anti-Cancer Effects in Hela Cancer Cell Line: A Morphological Study

Background: Co-administration of two or several either chemotherapeutic agents or conventional drugs as a combination treatment is the most effective method to increase therapeutic efficiency. Additive or synergistic influence are two mechanisms by which combination therapy causes a rise in optimal...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Hossein Majidzadeh, Mostafa Araj-Khodaei, Maryam Ghaffari, Amir Jafari, Dariush Shanehbandi, Mohammadali Torbati, Jafar Ezzati Nazhad Dolatabadi
Formato: article
Lenguaje:EN
Publicado: Tabriz University of Medical Sciences 2021
Materias:
Acceso en línea:https://doaj.org/article/dde0705bc4b14d4b882963ec9d3e323b
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:dde0705bc4b14d4b882963ec9d3e323b
record_format dspace
spelling oai:doaj.org-article:dde0705bc4b14d4b882963ec9d3e323b2021-11-29T05:53:09ZThe Combination of Berberine and Methotrexate Enhances Anti-Cancer Effects in Hela Cancer Cell Line: A Morphological Study2383-288610.34172/PS.2021.12https://doaj.org/article/dde0705bc4b14d4b882963ec9d3e323b2021-12-01T00:00:00Zhttps://ps.tbzmed.ac.ir/PDF/ps-27-536.pdfhttps://doaj.org/toc/2383-2886Background: Co-administration of two or several either chemotherapeutic agents or conventional drugs as a combination treatment is the most effective method to increase therapeutic efficiency. Additive or synergistic influence are two mechanisms by which combination therapy causes a rise in optimal cancer therapy compared to a single treatment. Methods: Colorimetric assay was carried out to estimate the cytotoxicity of the combined system, followed by apoptosis assay to calculate the number of apoptotic cells. Both 4′,6-diamidino-2-phenylindole (DAPI) staining and DNA ladder were complemented tests to illuminate morphological changes and DNA fracturing on HeLa cancer cells. Results: We revealed that the combination of berberine (BER) and methotrexate (MTX) could inhibit the growth of HeLa cancer cells noticeably. Nevertheless, single BER and MTX were not as effective as a combined system to reduce cell viability at the same dose. Regarding the apoptosis induction and change in morphology of cancer cells’ nucleus, co-treatment of BERand MTX was more effective. The result was complemented with flow cytometry, DAPI staining and DNA ladder, which showed that BER+MTX depicted more anti-cancer effects. Conclusion: The combination therapy of HeLa cancer cells with BER and MTX showed high inhibition effect compared to other treated groups.Hossein MajidzadehMostafa Araj-KhodaeiMaryam GhaffariAmir JafariDariush ShanehbandiMohammadali TorbatiJafar Ezzati Nazhad DolatabadiTabriz University of Medical Sciencesarticlehela cellsmethotrexateberberineherbal medicinenuclear morphologyPharmacy and materia medicaRS1-441ENPharmaceutical Sciences, Vol 27, Iss 4, Pp 536-542 (2021)
institution DOAJ
collection DOAJ
language EN
topic hela cells
methotrexate
berberine
herbal medicine
nuclear morphology
Pharmacy and materia medica
RS1-441
spellingShingle hela cells
methotrexate
berberine
herbal medicine
nuclear morphology
Pharmacy and materia medica
RS1-441
Hossein Majidzadeh
Mostafa Araj-Khodaei
Maryam Ghaffari
Amir Jafari
Dariush Shanehbandi
Mohammadali Torbati
Jafar Ezzati Nazhad Dolatabadi
The Combination of Berberine and Methotrexate Enhances Anti-Cancer Effects in Hela Cancer Cell Line: A Morphological Study
description Background: Co-administration of two or several either chemotherapeutic agents or conventional drugs as a combination treatment is the most effective method to increase therapeutic efficiency. Additive or synergistic influence are two mechanisms by which combination therapy causes a rise in optimal cancer therapy compared to a single treatment. Methods: Colorimetric assay was carried out to estimate the cytotoxicity of the combined system, followed by apoptosis assay to calculate the number of apoptotic cells. Both 4′,6-diamidino-2-phenylindole (DAPI) staining and DNA ladder were complemented tests to illuminate morphological changes and DNA fracturing on HeLa cancer cells. Results: We revealed that the combination of berberine (BER) and methotrexate (MTX) could inhibit the growth of HeLa cancer cells noticeably. Nevertheless, single BER and MTX were not as effective as a combined system to reduce cell viability at the same dose. Regarding the apoptosis induction and change in morphology of cancer cells’ nucleus, co-treatment of BERand MTX was more effective. The result was complemented with flow cytometry, DAPI staining and DNA ladder, which showed that BER+MTX depicted more anti-cancer effects. Conclusion: The combination therapy of HeLa cancer cells with BER and MTX showed high inhibition effect compared to other treated groups.
format article
author Hossein Majidzadeh
Mostafa Araj-Khodaei
Maryam Ghaffari
Amir Jafari
Dariush Shanehbandi
Mohammadali Torbati
Jafar Ezzati Nazhad Dolatabadi
author_facet Hossein Majidzadeh
Mostafa Araj-Khodaei
Maryam Ghaffari
Amir Jafari
Dariush Shanehbandi
Mohammadali Torbati
Jafar Ezzati Nazhad Dolatabadi
author_sort Hossein Majidzadeh
title The Combination of Berberine and Methotrexate Enhances Anti-Cancer Effects in Hela Cancer Cell Line: A Morphological Study
title_short The Combination of Berberine and Methotrexate Enhances Anti-Cancer Effects in Hela Cancer Cell Line: A Morphological Study
title_full The Combination of Berberine and Methotrexate Enhances Anti-Cancer Effects in Hela Cancer Cell Line: A Morphological Study
title_fullStr The Combination of Berberine and Methotrexate Enhances Anti-Cancer Effects in Hela Cancer Cell Line: A Morphological Study
title_full_unstemmed The Combination of Berberine and Methotrexate Enhances Anti-Cancer Effects in Hela Cancer Cell Line: A Morphological Study
title_sort combination of berberine and methotrexate enhances anti-cancer effects in hela cancer cell line: a morphological study
publisher Tabriz University of Medical Sciences
publishDate 2021
url https://doaj.org/article/dde0705bc4b14d4b882963ec9d3e323b
work_keys_str_mv AT hosseinmajidzadeh thecombinationofberberineandmethotrexateenhancesanticancereffectsinhelacancercelllineamorphologicalstudy
AT mostafaarajkhodaei thecombinationofberberineandmethotrexateenhancesanticancereffectsinhelacancercelllineamorphologicalstudy
AT maryamghaffari thecombinationofberberineandmethotrexateenhancesanticancereffectsinhelacancercelllineamorphologicalstudy
AT amirjafari thecombinationofberberineandmethotrexateenhancesanticancereffectsinhelacancercelllineamorphologicalstudy
AT dariushshanehbandi thecombinationofberberineandmethotrexateenhancesanticancereffectsinhelacancercelllineamorphologicalstudy
AT mohammadalitorbati thecombinationofberberineandmethotrexateenhancesanticancereffectsinhelacancercelllineamorphologicalstudy
AT jafarezzatinazhaddolatabadi thecombinationofberberineandmethotrexateenhancesanticancereffectsinhelacancercelllineamorphologicalstudy
AT hosseinmajidzadeh combinationofberberineandmethotrexateenhancesanticancereffectsinhelacancercelllineamorphologicalstudy
AT mostafaarajkhodaei combinationofberberineandmethotrexateenhancesanticancereffectsinhelacancercelllineamorphologicalstudy
AT maryamghaffari combinationofberberineandmethotrexateenhancesanticancereffectsinhelacancercelllineamorphologicalstudy
AT amirjafari combinationofberberineandmethotrexateenhancesanticancereffectsinhelacancercelllineamorphologicalstudy
AT dariushshanehbandi combinationofberberineandmethotrexateenhancesanticancereffectsinhelacancercelllineamorphologicalstudy
AT mohammadalitorbati combinationofberberineandmethotrexateenhancesanticancereffectsinhelacancercelllineamorphologicalstudy
AT jafarezzatinazhaddolatabadi combinationofberberineandmethotrexateenhancesanticancereffectsinhelacancercelllineamorphologicalstudy
_version_ 1718407616306085888